| Drug Name: | Indapamide (26807-65-8) |
|---|---|
| PubChem ID: | 3702 |
| SMILES: | CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N |
| InchiKey: | NDDAHWYSQHTHNT-UHFFFAOYSA-N |
| Therapeutic Category: | Antihypertensive Agents, Cardiovascular Agents, Diuretics, Membrane Transport Modulators, Natriuretic Agents, Sodium Chloride Symporter Inhibitors |
| Molecular Weight (dalton) | : | 365.842 |
| LogP | : | 2.0834 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 92.5 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Tremors | Cholecystokinin octapeptide (P01356) | The CCK-like peptides may play a physiological role in the regulation of extrapyramidal motor activity,which leads to tremors induced by oxotremorine, harmine and ibogaine. [ ADR Type 5 ] | Zetler G Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam Neuropharmaco |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category